SELLAS Life Sciences Prices $150 Million Public Offering at $13 a Share
Bitget2026/11/19 02:59- Sellas Life Sciences priced an underwritten public offering of 11,538,462 shares of common stock at $13 per share.
- Gross proceeds are expected to total $150 million before underwriting discounts, commissions and offering expenses.
- Underwriters have a 30-day option to buy 1,730,769 additional common shares at $13 each, less underwriting discounts and commissions.
- The offering is expected to close on November 20, 2026, subject to customary closing conditions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Circle issues 500 million USDC on the Solana network

Cardano vs Solana: Analysts and ADA Holders Clash Over Adoption

Ming-Chi Kuo: Google reduces next year's Broadcom-designed TPU shipments by 20% and plans to increase MediaTek's share
Renowned Apple and supply chain analyst Ming-Chi Kuo pointed out that Google has reduced the 2027 shipment volume of the TPU 8i series, designed by Broadcom, by about 1 million units, while planning to increase its procurement of the TPU 8t, designed by MediaTek. This move reflects that, limited by power and supply chain constraints, Google is prioritizing its computing resources towards the development of cutting-edge models.

